A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinoma.
Saved in:
| Title: | A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinoma. |
|---|---|
| Authors: | Ladwa R; Department of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia.; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia., Chandra J; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia., Woo WP; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Jingang Medicine (Australia) Pty Ltd, Brisbane, Australia., Finlayson N; Jingang Medicine (Australia) Pty Ltd, Brisbane, Australia., Liu H; Department of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia.; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia., McGrath M; Department of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia., See A; Department of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia., Hughes BG; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Department of Cancer Services, Royal Brisbane Hospital, Brisbane, Australia., Cooper CL; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Pathology Queensland, Princess Alexandra Hospital, Brisbane, Australia., Jackson JE; Department of Cancer Services, Gold Coast University Hospital, Gold Coast, Australia., Dzienis M; Department of Cancer Services, Gold Coast University Hospital, Gold Coast, Australia., Xu Y; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Jingang Medicine (Australia) Pty Ltd, Brisbane, Australia., Panizza B; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia.; ENT Department, Princess Alexandra Hospital, Brisbane, Australia., Frazer I; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Jingang Medicine (Australia) Pty Ltd, Brisbane, Australia., Porceddu SV; Department of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia.; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia. |
| Source: | Frontiers in oncology [Front Oncol] 2024 Jul 05; Vol. 14, pp. 1419258. Date of Electronic Publication: 2024 Jul 05 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39035738 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ladwa+R%22">Ladwa R</searchLink>; Department of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia.; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Chandra+J%22">Chandra J</searchLink>; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Woo+WP%22">Woo WP</searchLink>; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Jingang Medicine (Australia) Pty Ltd, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Finlayson+N%22">Finlayson N</searchLink>; Jingang Medicine (Australia) Pty Ltd, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Liu+H%22">Liu H</searchLink>; Department of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia.; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22McGrath+M%22">McGrath M</searchLink>; Department of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22See+A%22">See A</searchLink>; Department of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Hughes+BG%22">Hughes BG</searchLink>; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Department of Cancer Services, Royal Brisbane Hospital, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Cooper+CL%22">Cooper CL</searchLink>; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Pathology Queensland, Princess Alexandra Hospital, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Jackson+JE%22">Jackson JE</searchLink>; Department of Cancer Services, Gold Coast University Hospital, Gold Coast, Australia.<br /><searchLink fieldCode="AU" term="%22Dzienis+M%22">Dzienis M</searchLink>; Department of Cancer Services, Gold Coast University Hospital, Gold Coast, Australia.<br /><searchLink fieldCode="AU" term="%22Xu+Y%22">Xu Y</searchLink>; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Jingang Medicine (Australia) Pty Ltd, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Panizza+B%22">Panizza B</searchLink>; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia.; ENT Department, Princess Alexandra Hospital, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Frazer+I%22">Frazer I</searchLink>; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Jingang Medicine (Australia) Pty Ltd, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Porceddu+SV%22">Porceddu SV</searchLink>; Department of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia.; Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2024 Jul 05; Vol. 14, pp. 1419258. <i>Date of Electronic Publication: </i>2024 Jul 05 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39035738 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2024.1419258 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1419258 Titles: – TitleFull: A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ladwa R – PersonEntity: Name: NameFull: Chandra J – PersonEntity: Name: NameFull: Woo WP – PersonEntity: Name: NameFull: Finlayson N – PersonEntity: Name: NameFull: Liu H – PersonEntity: Name: NameFull: McGrath M – PersonEntity: Name: NameFull: See A – PersonEntity: Name: NameFull: Hughes BG – PersonEntity: Name: NameFull: Cooper CL – PersonEntity: Name: NameFull: Jackson JE – PersonEntity: Name: NameFull: Dzienis M – PersonEntity: Name: NameFull: Xu Y – PersonEntity: Name: NameFull: Panizza B – PersonEntity: Name: NameFull: Frazer I – PersonEntity: Name: NameFull: Porceddu SV IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 07 Text: 2024 Jul 05 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |
